Donors Delivering for SRHR is an annual publication analysing and ranking the latest data available to track the disbursements of members of the Organisation for Economic Co-operation and Development (OECD)’s Development Assistance Committee (DAC) to SRHR, reproductive, maternal, newborn and child health (RMNCH), and family planning (FP), as part of their Official Development Aid (ODA).
2023 REPORT KEY FINDINGS
After a significant increase from 2019 to 2020, donors’ total SRHR funding continued to increase in 2021, albeit to a lesser extent. The joint SRHR funding of all OECD DAC donors as a percentage of their total ODA also increased significantly from 2019 to 2020. The percentage decreased again in 2021 because the increase of all OECD DAC donors‘ ODA was considerably higher than the increase of SRHR disbursements.
Despite the increase of donors‘ total funding towards SRHR, the sometimes considerable amounts of SRHR funding often only represent a small share of donors‘ total ODA. Just as in previous years, especially some of the larger donors such as the EU Institutions, Italy, Germany or France fail to prioritise SRHR funding in their international cooperation, leaving room for improvement. Italy and the EU spent 1.76% and 1.92% respectively, while Germany and France allocated just slightly over 2% of their ODA to SRHR.
A number of countries truly champion SRHR in their international collaboration: the US was the largest SRHR donor by far (both in absolute and relative terms), with over 16% of its ODA spent on SRHR. This was the result of its strong support towards STD control including the fight against HIV & Aids. Other SRHR champions include Canada, the Netherlands, Sweden, Iceland, Norway and Luxembourg, who allocated between 5.26% and 8.33% of their ODA to SRHR.
FOLLOW US ON TWITTER
🌐 In a time of global setbacks on #SRHR, the 75th anniversary of the ...Universal Declaration of Human Rights reminds us that upholding #SRHR is crucial to keeping the promise of human rights for all. Let's stand firm for these fundamental rights!
#HumanRights75
📢 Mark your calendars! The annual Neglected Disease #GFINDER report will ...launch on January 31, 2024.
Join us to explore the investment landscape for neglected disease R&D & product pipeline.
🎟️Registration: http://bit.ly/3RsxQyx
📖Last year's report: http://bit.ly/3HbAxOB
The EU's commitment to #SRHR is carried out through various policies & ...agreements, but how does this translate into concrete programmes & activities?
Read our key findings & recommendations on how the 🇪🇺 can address SRHR in a holistic & effective way!
👉 https://www.dsw.org/en/wp-content/uploads/2023/11/FACTSHEET-The-EUs-bilateral-cooperation-with-partner-countries-FINAL.pdf
3 days to go till our 6th #AccesstoMedicines Forum!
Explore crucial topics ...like pharmaceutical legislation, antibiotic development & fair pricing & listen to insights from our ten distinguished speakers.
📆8 Dec
🕤9:30-13:00 CET
Have you registered yet?🔗https://us02web.zoom.us/webinar/register/WN_FImQOcGYRzyedlvSWRfV8A#/registration